PREMARIN

LOE Approaching

conjugated estrogens

NDAINJECTIONINJECTABLE
Approved
Dec 1956
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
20

Mechanism of Action

Estrogen Receptor Agonists

Pharmacologic Class:

Estrogen

Clinical Trials (5)

NCT02100553Phase 1Completed

Study Evaluating Effects of Multiple-Dose Administration of Itraconazole on the Single Dose Pharmacokinetics of Conjugated Estrogens/Bazedoxifene in Non-Obese and Obese Postmenopausal Women

Started Apr 2014
24 enrolled
Healthy
NCT01634789Phase 1Terminated

A Pilot Bioavailability Study of 3 Test Tablet Formulations of Bazedoxifene Compared With A Reference Tablet Formulation of Bazedoxifene/Conjugated Estrogens in Healthy Postmenopausal Women

Started Aug 2012
2 enrolled
Healthy
NCT01613170Phase 4Unknown

Premarin Versus Toviaz for Treatment of Overactive Bladder

Started Apr 2012
90 enrolled
Overactive Bladder
NCT01436513Phase 1Completed

A Study To Compare The Amount Of Premarin Components That Is Absorbed Into The Blood Of Japanese Healthy Postmenopausal Women Following Oral Administration Of Two Different Tablets Of Premarin Under Fast and Fed Conditions.

Started Oct 2011
72 enrolled
Primary Ovarian InsufficiencyVaginitisMetrorrhagia+1 more
NCT00847821N/ATerminated

Observational Study Analyzing RNA Expression Of Endometrial Biopsy Samples From Placebo, Bazedoxifene/Conjugated Estrogens And Raloxifene

Started May 2009
185 enrolled
Postmenopause